These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7525156)

  • 21. Hepatitis C virus antibodies in dialysis pediatric patients.
    Di Loreto M; Ferrante M; Panaro A; Sorino P; Collela V; Caringella DA
    Nephron; 1992; 61(3):365-6. PubMed ID: 1323793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of NS3 and NS5 antigens in screening for HCV antibody.
    Goffin E; Pirson Y; Cornu C; Jadoul M; van Ypersele de Strihou C
    Lancet; 1994 Apr; 343(8901):854. PubMed ID: 7511196
    [No Abstract]   [Full Text] [Related]  

  • 23. Testing for HCV markers.
    Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
    Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative characterization of test systems in the diagnosis of viral hepatitis C].
    Bogach VV; Trotsenko OE; Davidovich MA
    Klin Lab Diagn; 1995; (4):38-9. PubMed ID: 7670820
    [No Abstract]   [Full Text] [Related]  

  • 25. Enhanced detection of antibodies to hepatitis C virus by use of a third-generation recombinant immunoblot assay.
    Buffet C; Charnaux N; Laurent-Puig P; Chopineau S; Quichon JP; Briantais MJ; Dussaix E
    J Med Virol; 1994 Jul; 43(3):259-61. PubMed ID: 7523581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-GOR without anti-HCV core is not associated with hepatitis C viremia.
    Bååth L; Widell A
    Vox Sang; 1994; 66(2):151. PubMed ID: 7514327
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antibodies against hepatitis C virus. Experience with a second generation test].
    Garassini MA; Ortega F; Alvarado M; Valdés A; Díaz F; Dugarte I; Serrano L
    G E N; 1991; 45(3):183-9. PubMed ID: 1726913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus antibodies in patients with chronic liver disease: ELISA and RIBA HCV strip immunoblot assay results.
    Baskin G; DiNello R; Polito A; Quan S; Lee WS; Wu J; Nelles M; Lee S
    Gut; 1993; 34(2 Suppl):S61. PubMed ID: 7686119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody to hepatitis C virus in 1,305 Italian multiply transfused thalassaemics: a comparison of first and second generation tests. Cooleycare Group.
    Rebulla P; Mozzi F; Contino G; Locatelli E; Sirchia G
    Transfus Med; 1992 Mar; 2(1):69-70. PubMed ID: 1284983
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis C virus antibody in Swaziland.
    Aceti A; Taliani G; Bruni R; Di Mauro G; Celestino D
    Acta Trop; 1992 Jun; 51(2):159-61. PubMed ID: 1380766
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors.
    Yun ZB; Lindh G; Weiland O; Johansson B; Sönnerborg A
    J Med Virol; 1993 Jan; 39(1):57-61. PubMed ID: 7678638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus markers and de novo liver disease after transplantation: a prospective study.
    Franco A; Muñoz C; Jimenez L; Verdejo F; Arenas D; Olivares J
    Transplant Proc; 1995 Aug; 27(4):2260-1. PubMed ID: 7544499
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatitis C virus and serologic tests for detection of viral hepatitis C].
    Bode JC; Alscher DM
    Med Klin (Munich); 1992 Oct; 87(10):527-31, 549. PubMed ID: 1334216
    [No Abstract]   [Full Text] [Related]  

  • 34. Low cost anti-HCV screening of blood donors.
    Neill AG; Conradie JD
    Lancet; 1992 Oct; 340(8827):1096. PubMed ID: 1357481
    [No Abstract]   [Full Text] [Related]  

  • 35. Follow-up study of anti-hepatitis C virus antibodies in blood donors implicated in post-transfusion non-A, non-B hepatitis.
    Mazda T; Nakata K; Bannai M; Miyamura T; Chiba J; Ohba H; Kaminuma Y; Katayama T
    Transfus Med; 1993 Jun; 3(2):149-51. PubMed ID: 7690640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune hepatitis and hepatitis C virus infection.
    Lohse AW; Gerken G; Meyer zum Büschenfelde KH
    Curr Stud Hematol Blood Transfus; 1994; (61):89-97. PubMed ID: 7525157
    [No Abstract]   [Full Text] [Related]  

  • 37. [Non A, non B hepatitis].
    Oubiña JR
    Medicina (B Aires); 1991; 51(4):377-9. PubMed ID: 1668292
    [No Abstract]   [Full Text] [Related]  

  • 38. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

  • 39. Definition of false-positive reactions in screening for hepatitis C virus antibodies.
    Schröter M; Feucht HH; Schäfer P; Zöllner B; Polywka S; Laufs R
    J Clin Microbiol; 1999 Jan; 37(1):233-4. PubMed ID: 9854100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of NS3 and NS5 antigens in screening for HCV antibody.
    Vernelen K; Claeys H; Verhaert H; Volckaerts A; Vermylen C
    Lancet; 1994 Apr; 343(8901):853. PubMed ID: 7511194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.